AI-Generated Before and After Photos in Medical Aesthetics
Assess demand and risk for AI-generated before-and-after photos in medical aesthetics, including consent, realism, disclosure, and advertising compliance.
Representative source image: official ModMed Scribe product page.
Quick answer: AI-generated before-and-after photos in medical aesthetics can support concept visualization, but clinics should avoid misleading outcome claims. Any use should be clearly disclosed, separated from real patient results, and reviewed against advertising, consent, and platform policies.
Who this guide is for
Medical aesthetics clinics, plastic surgery marketers, dermatology practices, and compliance reviewers.
What makes this workflow different
Generated images can mislead patients if they are not clearly disclosed and separated from real outcomes.
What to verify before using it
Disclose when an image is AI-generated or simulated.
Do not present generated images as real patient outcomes.
Review state board, advertising, and platform rules.
Avoid unrealistic or guaranteed results.
Keep consent documentation for real patient imagery.
Risk level and safe use
Medical risk
Medium
Best first step
Write the workflow in one sentence, decide who reviews the AI output, and test with a small controlled pilot before expanding.
Recommended posture
Use AI as supervised workflow support. Verify sources, privacy, human review, and regulatory fit before relying on outputs.
Source-backed products for this workflow
These profiles are not rankings. They are starting points for checking vendor claims, privacy terms, FDA or regulatory posture, evidence, and workflow fit.
ModMed describes Scribe 2.0 as an ambient AI documentation solution built into EMA EHR that suggests structured notes, billing codes, and downstream clinical workflow actions for specialty practices.
Best for
Specialty practices already using, or evaluating, ModMed workflows where native EHR integration matters more than standalone transcription.
First check
Whether your specialty and EMA workflow are supported.
CureMetrix describes FDA-cleared cmTriage for mammography worklist triage and separate cmAssist CAD materials; the FDA 510(k) database lists cmTriage as radiological computer-assisted prioritization software for lesions under K183285.
Best for
Breast imaging programs evaluating suspicious-case prioritization for 2D screening mammography while keeping radiologists responsible for interpretation.
First check
Whether the exact CureMetrix module is cmTriage, cmAssist, or another breast-imaging workflow.
Lunit describes a cancer AI ecosystem spanning screening, diagnosis, treatment decisions, and drug development, including Lunit INSIGHT radiology products and Lunit SCOPE precision-oncology and pathology products; FDA-listed records and Lunit regulatory pages should be checked for product-specific status.
Best for
Organizations evaluating cancer-screening AI, mammography or chest X-ray support, and oncology research workflows that need product-specific regulatory review.
First check
Which module is in scope: INSIGHT MMG, INSIGHT DBT, INSIGHT CXR, SCOPE IO, SCOPE IHC, SCOPE GP, or a Volpara-derived workflow.
Abridge describes ambient clinical documentation with provenance and clinician review, and publishes separate privacy and trust-center materials for due diligence.
Best for
Health systems seeking an enterprise ambient documentation platform.
First check
BAA, audio, transcript, and training-data terms.
Sources
3 official sources
Official source trail for this workflow
Open these vendor, documentation, privacy, or regulatory sources before relying on product claims, especially for FDA status, PHI handling, deployment model, and intended use.
Find the best AI for medical workflows by matching the tool to documentation, questions, diagnosis support, research, coding, billing, imaging, or practice operations.
Understand AI for medical diagnosis, including validation evidence, FDA status, clinical supervision, and why patient-specific diagnosis should not rely on general chatbots.